Association between toenail mercury and metabolic syndrome is modified by selenium

Nutrients

Volumn 8, Issue 7, 2016, Pages

  Park, Kyong ^a   Seo, Eunmin ^a  

^a Yeungnam University   (South Korea)

Author keywords

Asian; Effect modification; Metabolic syndrome; Selenium; Toenail mercury

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MERCURY; SELENIUM; TRIACYLGLYCEROL;

ADULT; ALCOHOL CONSUMPTION; ANTHROPOMETRY; ARTICLE; BODY MASS; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DRINKING BEHAVIOR; FEMALE; FISH MEAT; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; FOOD POISONING; GLUCOSE BLOOD LEVEL; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MERCURIALISM; METABOLIC SYNDROME X; NAIL; NEUTRON ACTIVATION ANALYSIS; OBESITY; PHYSICAL ACTIVITY; SMOKING; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; ADVERSE EFFECTS; CATERING SERVICE; CHEMISTRY; FOOD CONTAMINATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITION; NUTRITIONAL STATUS; ODDS RATIO; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SEA FOOD; SOUTH KOREA; STATISTICAL MODEL; TIME FACTOR; TOE;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; FOOD CONTAMINATION; FOOD SUPPLY; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MERCURY; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; NAILS; NEUTRON ACTIVATION ANALYSIS; NUTRITION SURVEYS; NUTRITIONAL STATUS; ODDS RATIO; PREVALENCE; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; SEAFOOD; SELENIUM; TIME FACTORS; TOES;

EID: 84978511941     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8070424     Document Type: Article

References (48)

1. Grundy, S. M.; Cleeman, J. I.; Daniels, S. R.; Donato, K. A.; Eckel, R. H.; Franklin, B. A.; Gordon, D. J.; Krauss, R. M.; Savage, P. J.; Smith, S. C., Jr.; et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement: Executive summary. Crit. Pathw. Cardiol. 2005, 4, 198-203. [CrossRef] [PubMed].
2. McNeill, A. M.; Rosamond, W. D.; Girman, C. J.; Golden, S. H.; Schmidt, M. I.; East, H. E.; Ballantyne, C. M.; Heiss, G. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005, 28, 385-390. [CrossRef] [PubMed].
3. Bonora, E.; Targher, G.; Formentini, G.; Calcaterra, F.; Lombardi, S.; Marini, F.; Zenari, L.; Saggiani, F.; Poli, M.; Perbellini, S.; et al. The metabolic syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study. Diabet. Med. 2004, 21, 52-58. [CrossRef] [PubMed].
4. Deurenberg, P.; Deurenberg-Yap, M.; Guricci, S. Asians are different from Caucasians and from each other in their body mass index/body fat percent relationship. Obesity Rev. 2002, 3, 141-146. [CrossRef].
5. Ram, C. V. S.; Farmer, J. A. Metabolic syndrome in South Asians. J. Clin. Hypertens. 2012, 14, 561-565. [CrossRef] [PubMed].
6. York, R.; Gossard, M. H. Cross-national meat and fish consumption: Exploring the effects of modernization and ecological context. Ecol. Econ. 2004, 48, 293-302. [CrossRef].
7. Kearney, J. Food consumption trends and drivers. Philos. Trans. R Soc. Lond. B Biol. Sci. 2010, 365, 2793-2807. [CrossRef] [PubMed].
8. Food and Agriculture Organization. Livestock and Fish Primary Equivalent. Available online: http://faostat. fao. org/site/610/DesktopDefault. aspx?PageID= 610#ancor (accessed on 8 June 2016).
9. Mozaffarian, D.; Rimm, E. B. Fish intake, contaminants, and human health: Evaluating the risks and the benefits. JAMA 2006, 296, 1885-1899. [CrossRef] [PubMed].
10. Hightower, J. M.; Moore, D. Mercury levels in high-end consumers of fish. Environ. Health Perspect. 2003, 111, 604-608. [CrossRef] [PubMed].
11. Mahaffey, K. R. Methylmercury: A new look at the risks. Public Health Rep. 1999, 114, 396-399, 402-413. [PubMed].
12. Committee on the Toxicological Effects of Methylmercury; Board on Environmental Studies and Toxicology; Commission on Life Sciences; National Research Council. Toxicological Effects of Methylmercury; National Academy Press: Washington, DC, USA, 2000.
13. Rice, D. C.; Schoeny, R.; Mahaffey, K. Methods and rationale for derivation of a reference dose for methylmercury by the U. S. EPA. Risk Anal. 2003, 23, 107-115. [CrossRef] [PubMed].
14. Rice, D. C. The U. S. EPA reference dose for methylmercury: Sources of uncertainty. Environ. Res. 2004, 95, 406-413. [CrossRef] [PubMed].
15. Chan, H. M.; Egeland, G. M. Fish consumption, mercury exposure, and heart diseases. Nutr. Rev. 2004, 62, 68-72. [PubMed].
16. Magos, L. Physiology and toxicology of mercury. Met. Ions Biol. Syst. 1997, 34, 321-370. [PubMed].
17. Jansson, G.; Harms-Ringdahl, M. Stimulating effects of mercuric-and silver ions on the superoxide anion production in human polymorphonuclear leukocytes. Free Radic. Res. Commun. 1993, 18, 87-98. [CrossRef] [PubMed].
18. Clarkson, T. W. The toxicology of mercury. Crit. Rev. Clin. Lab. Sci. 1997, 34, 369-403. [CrossRef] [PubMed].
19. Tinkov, A. A.; Ajsuvakova, O. P.; Skalnaya, M. G.; Popova, E. V.; Sinitskii, A. I.; Nemereshina, O. N.; Gatiatulina, E. R.; Nikonorov, A. A.; Skalny, A. V. Mercury and metabolic syndrome: A review of experimental and clinical observations. Biometals 2015, 28, 231-254. [CrossRef] [PubMed].
20. Welty, F. K.; Alfaddagh, A.; Elajami, T. K. Targeting inflammation in metabolic syndrome. Transl. Res. J. Lab. Clin. Med. 2016, 167, 257-280. [CrossRef] [PubMed].
21. Iwata, H.; Masukawa, T.; Kito, H.; Hayashi, M. Degradation of methylmercury by selenium. Life Sci. 1982, 31, 859-866. [CrossRef].
22. Park, S. B.; Choi, S. W.; Nam, A. Y. Hair tissue mineral analysis and metabolic syndrome. Biol. Trace Elem. Res. 2009, 130, 218-228. [CrossRef] [PubMed].
23. Eom, S. Y.; Choi, S. H.; Ahn, S. J.; Kim, D. K.; Kim, D. W.; Lim, J. A.; Choi, B. S.; Shin, H. J.; Yun, S. W.; Yoon, H. J.; et al. Reference levels of blood mercury and association with metabolic syndrome in Korean adults. Int. Arch. Occup. Environ. Health 2014, 87, 501-513. [CrossRef] [PubMed].
24. Rhee, S. Y.; Hwang, Y. C.; Woo, J. T.; Sinn, D. H.; Chin, S. O.; Chon, S.; Kim, Y. S. Blood lead is significantly associated with metabolic syndrome in Korean adults: An analysis based on the Korea National Health and Nutrition Examination Survey (KNHANES), 2008. Cardiovasc. Diabetol. 2013, 12, 9. [CrossRef] [PubMed].
25. Lee, B. K.; Kim, Y. Blood cadmium, mercury, and lead and metabolic syndrome in South Korea: 2005-2010 Korean national health and nutrition examination survey. Am. J. Ind. Med. 2013, 56, 682-692. [CrossRef] [PubMed].
26. Moon, S. S. Additive effect of heavy metals on metabolic syndrome in the Korean population: The Korea National Health and Nutrition Examination Survey (KNHANES) 2009-2010. Endocrine 2014, 46, 263-271. [CrossRef] [PubMed].
27. Chung, J. Y.; Seo, M. S.; Shim, J. Y.; Lee, Y. J. Sex differences in the relationship between blood mercury concentration and metabolic syndrome risk. J. Endocrinol. Investig. 2015, 38, 65-71. [CrossRef] [PubMed].
28. Garland, M.; Morris, J. S.; Rosner, B. A.; Stampfer, M. J.; Spate, V. L.; Baskett, C. J.; Willett, W. C.; Hunter, D. J. Toenail trace element levels as biomarkers: Reproducibility over a 6-year period. Cancer Epidemiol. Biomark. Prev. 1993, 2, 493-497.
29. Slotnick, M. J.; Nriagu, J. O. Validity of human nails as a biomarker of arsenic and selenium exposure: A review. Environ. Res. 2006, 102, 125-139. [CrossRef] [PubMed].
30. He, K.; Xun, P.; Liu, K.; Morris, S.; Reis, J.; Guallar, E. Mercury exposure in young adulthood and incidence of diabetes later in life: The cardia trace element study. Diabetes Care 2013, 36, 1584-1589. [CrossRef] [PubMed].
31. Mozaffarian, D.; Shi, P.; Morris, J. S.; Grandjean, P.; Siscovick, D. S.; Spiegelman, D.; Willett, W. C.; Rimm, E. B.; Curhan, G. C.; Forman, J. P. Mercury exposure and risk of hypertension in U. S. men and women in 2 prospective cohorts. Hypertension 2012, 60, 645-652. [CrossRef] [PubMed].
32. Fleckman, P. Basic science of the nail unit. In Nails: Therapy, Diagnosis, Surgery; Scher, R. K., Daniel, C. R., Eds.; Saunders: Philadelphia, PA, USA, 1997; Volume 2, pp. 37-54.
33. MacIntosh, D. L.; Williams, P. L.; Hunter, D. J.; Sampson, L. A.; Morris, S. C.; Willett, W. C.; Rimm, E. B. Evaluation of a food frequency questionnaire-food composition approach for estimating dietary intake of inorganic arsenic and methylmercury. Cancer Epidemiol. Biomark. Prev. 1997, 6, 1043-1050.
34. Joshi, A.; Douglass, C. W.; Kim, H. D.; Joshipura, K. J.; Park, M. C.; Rimm, E. B.; Carino, M. J.; Garcia, R. I.; Morris, J. S.; Willett, W. C. The relationship between amalgam restorations and mercury levels in male dentists and nondental health professionals. J. Public Health Dent. 2003, 63, 52-60. [CrossRef] [PubMed].
35. Mozaffarian, D.; Shi, P.; Morris, J. S.; Spiegelman, D.; Grandjean, P.; Siscovick, D. S.; Willett, W. C.; Rimm, E. B. Mercury exposure and risk of cardiovascular disease in two U. S. Cohorts. N. Engl. J. Med. 2011, 364, 1116-1125. [CrossRef] [PubMed].
36. Ainsworth, B. E.; Haskell, W. L.; Leon, A. S.; Jacobs, D. R., Jr.; Montoye, H. J.; Sallis, J. F.; Paffenbarger, R. S., Jr. Compendium of physical activities: Classification of energy costs of human physical activities. Med. Sci. Sports Exerc. 1993, 25, 71-80. [CrossRef] [PubMed].
37. Korean National Health Insurance Service. Health Checkup, Health Insurace Guide. Available online: http://www. nhis. or. kr/static/html/wbd/g/a/wbdga0606. html (accessed on 28 March 2016).
38. Grundy, S. M.; Cleeman, J. I.; Daniels, S. R.; Donato, K. A.; Eckel, R. H.; Franklin, B. A.; Gordon, D. J.; Krauss, R. M.; Savage, P. J.; Smith, S. C.; et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005, 112, 2735-2752. [CrossRef] [PubMed].
39. Alberti, K. G. M. M.; Eckel, R. H.; Grundy, S. M.; Zimmet, P. Z.; Cleeman, J. I.; Donato, K. A.; Fruchart, J.-C.; James, W. P. T.; Loria, C. M.; Smith, S. C. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120, 1640-1645. [PubMed].
40. World Health Organization. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Available online: http://www. wpro. who. int/nutrition/documents/Redefining_obesity/en/(accessed on 26 June 2016).
41. Cho, S.; Jacobs, D. R., Jr.; Park, K. Population correlates of circulating mercury levels in Korean adults: The Korea National Health and Nutrition Examination Survey IV. BMC Public Health 2014, 14, 527. [CrossRef] [PubMed].
42. Naganuma, A.; Koyama, Y.; Imura, N. Behavior of methylmercury in mammalian erythrocytes. Toxicol. Appl. Pharmacol. 1980, 54, 405-410. [CrossRef].
43. Park, K.; Rimm, E. B.; Siscovick, D. S.; Spiegelman, D.; Manson, J. E.; Morris, J. S.; Hu, F. B.; Mozaffarian, D. Toenail selenium and incidence of type 2 diabetes in U. S. men and women. Diabetes Care 2012, 35, 1544-1551. [CrossRef] [PubMed].
44. Beckett, G. J.; Arthur, J. R. Selenium and endocrine systems. J. Endocrinol. 2005, 184, 455-465. [CrossRef] [PubMed].
45. Seppanen, K.; Kantola, M.; Laatikainen, R.; Nyyssonen, K.; Valkonen, V. P.; Kaarlopp, V.; Salonen, J. T. Effect of supplementation with organic selenium on mercury status as measured by mercury in pubic hair. J. Trace Elements Med. Biol. 2000, 14, 84-87. [CrossRef].
46. Guallar, E.; Sanz-Gallardo, M. I.; van't Veer, P.; Bode, P.; Aro, A.; Gomez-Aracena, J.; Kark, J. D.; Riemersma, R. A.; Martin-Moreno, J. M.; Kok, F. J.; et al. Mercury, fish oils, and the risk of myocardial infarction. N. Engl. J. Med. 2002, 347, 1747-1754. [CrossRef] [PubMed].
47. Virtanen, J. K.; Voutilainen, S.; Rissanen, T. H.; Mursu, J.; Tuomainen, T. P.; Korhonen, M. J.; Valkonen, V. P.; Seppanen, K.; Laukkanen, J. A.; Salonen, J. T. Mercury, fish oils, and risk of acute coronary events and cardiovascular disease, coronary heart disease, and all-cause mortality in men in eastern Finland. Arterioscler. Thromb. Vasc. Biol. 2005, 25, 228-233. [CrossRef] [PubMed].
48. Yoshizawa, K.; Rimm, E. B.; Morris, J. S.; Spate, V. L.; Hsieh, C. C.; Spiegelman, D.; Stampfer, M. J.; Willett, W. C. Mercury and the risk of coronary heart disease in men. N. Engl. J. Med. 2002, 347, 1755-1760. [CrossRef] [PubMed].